SEROTONIN 5-HT3 ANTAGONISTS DO NOT ALTER THE DISCRIMINATIVE STIMULUS PROPERTIES OF COCAINE

被引:57
|
作者
PARIS, JM [1 ]
CUNNINGHAM, KA [1 ]
机构
[1] UNIV TEXAS,MED BRANCH,DEPT PHARMACOL & TOXICOL,GALVESTON,TX 77550
关键词
COCAINE; SEROTONIN; 5-HT3; ICS-205930; MDL-72222; DRUG DISCRIMINATION-BEHAVIOR; RAT;
D O I
10.1007/BF02245652
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The central nervous system (CNS) of the rat is known to contain serotonin (5-HT) type -3 receptors (5-HT3). Behavioral evidence suggests that 5-HT3 receptors interact with mesolimbic dopamine (DA) systems and that 5-HT3 antagonists can interfere with the hyperlocomotive effects of amphetamine and cocaine and the rewarding and stimulus effects of morphine, nicotine and ethanol. Cocaine, which blocks the reuptake of DA, norepinephrine (NE), and 5-HT in the CNS, also may be an antagonist at 5-HT3 receptors. The purpose of the present study was to determine whether systemic administration of the 5-HT3 antagonists ICS 205930 or MDL 72222 could mimic or block the discriminative stimulus properties of cocaine. Once rats (N = 16) were trained to discriminate cocaine (10 mg/kg) from saline, substitution tests with various doses of cocaine (0.313-10 mg/kg), ICS 205930 (2-24 mg/kg), and MDL 72222 (2-16 mg/kg) were conducted. Cocaine produced a dose-related increase in cocaine-appropriate responding while the 5-HT3 antagonists engendered primarily saline-lever responding. Neither ICS 205930 nor MDL 72222 were able to antagonize the stimulus effects of cocaine (5 mg/kg). Response rates were not significantly reduced when the 5-HT3 antagonists were given in combination with cocaine. The results indicate that although 5-HT3 antagonists can inhibit some of the unconditioned behavioral effects of psychomotor stimulants, the discriminative stimulus effects of cocaine remain intact.
引用
收藏
页码:475 / 478
页数:4
相关论文
共 50 条
  • [1] Dopamine and serotonin antagonists fail to alter the discriminative stimulus properties of ±methylenedioxymethamphetamine
    Schenk, Susan
    Highgate, Quenten
    BEHAVIOURAL PHARMACOLOGY, 2019, 30 (04): : 327 - 334
  • [2] Azologization of serotonin 5-HT3 receptor antagonists
    Rustler, Karin
    Maleeva, Galyna
    Bregestovski, Piotr
    Koenig, Burkhard
    BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2019, 15 : 780 - 788
  • [3] 5-HT3 receptor antagonists do not alter spontaneous contraction of pregnant myometrium in vitro
    Lin, Xuemei
    Du, Yu
    Tang, Yuying
    Zeng, Kui
    Ni, Juan
    Liu, Jin
    Zhou, Jie
    INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 2015, 24 (01) : 41 - 45
  • [4] GR38032F, A SEROTONIN 5-HT3 ANTAGONIST, FAILS TO ALTER COCAINE SELF-ADMINISTRATION IN RATS
    PELTIER, R
    SCHENK, S
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 39 (01) : 133 - 136
  • [5] EFFECT OF 5-HT(3) RECEPTOR ANTAGONISTS ON THE DISCRIMINATIVE STIMULUS PROPERTIES OF MORPHINE IN RATS
    JOHARCHI, N
    SELLERS, EM
    HIGGINS, GA
    PSYCHOPHARMACOLOGY, 1993, 112 (01) : 111 - 115
  • [6] Modulation of Paracetamol and Nefopam Antinociception by Serotonin 5-HT3 Receptor Antagonists in Mice
    Girard, Philippe
    Pansart, Yannick
    Coppe, Marie-Claude
    Niedergang, Betty
    Gillardin, Jean-Marie
    PHARMACOLOGY, 2009, 83 (04) : 243 - 246
  • [7] Pretreatment with serotonin 5-HT3 receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats
    Szumlinski, KK
    Frys, KA
    Kalivas, PW
    PSYCHOPHARMACOLOGY, 2003, 165 (04) : 329 - 336
  • [8] 5-HT3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats
    Cervo, L
    Pozzi, L
    Samanin, R
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 55 (01) : 33 - 37
  • [9] Discriminative stimulus properties of cocaine: enhancement by ββ-adrenergic receptor antagonists
    M. S. Kleven
    Wouter Koek
    Psychopharmacology, 1997, 131 : 307 - 312
  • [10] 5-HT3 RECEPTOR ANTAGONISTS BLOCK COCAINE-INDUCED LOCOMOTION VIA A PCPA-SENSITIVE MECHANISM
    SVINGOS, AL
    HITZEMANN, R
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (03) : 871 - 879